Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Int Forum Allergy Rhinol. 2018 Jun;8(6):668-675. doi: 10.1002/alr.22109. Epub 2018 Mar 8.
Disagreement exists about the relationship between Lund-Mackay CT scores (LMCTS) and quality-of-life outcome (QoL) measures. We investigated whether preoperative LMCTS are associated with preoperative QoL, and whether LMCTS is predictive of postoperative QoL outcomes in chronic rhinosinusitis (CRS) patients.
Adult patients with medically recalcitrant CRS (n = 665) were enrolled in a prospective, observational cohort study. Preoperative LMCTS and pre- and postoperative self-reported QoL outcomes (22-item Sino-Nasal Outcomes Test [SNOT-22]) were collected and evaluated over 12 months. Five hundred sixty-eight patients met the inclusion criteria. Longitudinal linear mixed-effects modeling was used to investigate the effect of LMCTS on QoL after functional endoscopic sinus surgery (FESS).
Preoperative LMCTS were significantly associated with preoperative SNOT-22 scores (p < 0.01) and postoperative SNOT-22 scores (p < 0.001), driven by Extranasal and Rhinologic subdomains of the QoL questionaire. Patients in the lowest preoperative LMCTS quartile had the lowest mean change in SNOT-22 scores at 12 months (16.8 points; 95% confidence interval [CI], 12.2-21.3). Patients in the second and third lowest preoperative LMCTS quartiles had mean changes at 12 months of 21.1 points (95% CI, 16.7-25.4) and 23.1 points (95% CI, 18.3-27.9). Patients in the highest preoperative LMCTS quartile had the greatest improvement in SNOT-22 scores after FESS (29.9 points; 95% CI, 24.9-34.8). The difference in QoL change at 12 months between the highest and lowest preoperative LMCTS quartiles was 13.1 points (95% CI, 6.0-20.2; p < 0.001).
Our study demonstrates that preoperative LMCTS correlate with preoperative extranasal and rhinologic symptom severity and that the LMCTS is an indicator of postsurgical QoL outcomes for medically recalcitrant chronic rhinosinusitis patients in a large tertiary otolaryngology setting.
Lund-Mackay CT 评分(LMCTS)与生活质量(QoL)测量结果之间的关系存在争议。我们研究了术前 LMCTS 是否与术前 QoL 相关,以及 LMCTS 是否可以预测慢性鼻-鼻窦炎(CRS)患者的术后 QoL 结果。
纳入了 665 例患有药物难治性 CRS 的成年患者,进行前瞻性观察队列研究。收集并评估了术前 LMCTS 和术前及术后自我报告的 QoL 结果(22 项鼻-鼻窦结局测试[SNOT-22]),并随访 12 个月。568 例患者符合纳入标准。使用纵向线性混合效应模型来研究 LMCTS 对功能性内镜鼻窦手术(FESS)后 QoL 的影响。
术前 LMCTS 与术前 SNOT-22 评分(p < 0.01)和术后 SNOT-22 评分(p < 0.001)显著相关,这主要归因于 QoL 问卷的鼻外和鼻科学亚域。术前 LMCTS 最低四分位数的患者在 12 个月时 SNOT-22 评分的平均变化最小(16.8 分;95%置信区间[CI],12.2-21.3)。术前 LMCTS 最低和第二、三分位数的患者在 12 个月时的平均变化分别为 21.1 分(95% CI,16.7-25.4)和 23.1 分(95% CI,18.3-27.9)。术前 LMCTS 最高四分位数的患者在 FESS 后 SNOT-22 评分的改善最大(29.9 分;95% CI,24.9-34.8)。12 个月时,术前 LMCTS 最高和最低四分位数之间的 QoL 变化差异为 13.1 分(95% CI,6.0-20.2;p < 0.001)。
我们的研究表明,术前 LMCTS 与术前鼻外和鼻科学症状严重程度相关,并且在大型耳鼻喉科三级机构中,LMCTS 是药物难治性慢性鼻-鼻窦炎患者术后 QoL 结果的指标。